Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Gary, T.
Cancer related venous thromboembolism - prophylaxis and therapy.
Vasa. 2014; 43(4):245-251 Doi: 10.1024/0301-1526/a000359
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Gary Thomas

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Cancer is a highly thrombophilic entity leading to a high rate of symptomatic and even asymptomatic venous thromboembolic (VTE) events in patients suffering from malignant disease. As VTE events have impact on survival and can be reduced significantly by anticoagulant treatment, guidelines on prophylaxis of these events by means of anticoagulation exist from various societies. Purpose of this review is to give a concise overview of current possibilities for prophylaxis and also for the therapy of VTE events in cancer patients.
Find related publications in this database (using NLM MeSH Indexing)
Anticoagulants - adverse effects
Anticoagulants - therapeutic use
Antineoplastic Agents - adverse effects
Blood Coagulation - drug effects
Heparin, Low-Molecular-Weight - adverse effects
Heparin, Low-Molecular-Weight - therapeutic use
Humans -
Neoplasms - blood
Neoplasms - complications
Neoplasms - drug therapy
Neoplasms - mortality
Practice Guidelines as Topic -
Risk Assessment -
Risk Factors -
Treatment Outcome -
Venous Thromboembolism - blood
Venous Thromboembolism - etiology
Venous Thromboembolism - mortality
Venous Thromboembolism - prevention & control

Find related publications in this database (Keywords)
venous thromboembolism
pulmonary embolism
low molecular weight heparin
© Med Uni Graz Impressum